297 results on '"Kellner, Herbert"'
Search Results
2. Fibromyalgie - wenn der ganze Körper schmerzt
3. Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
4. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
5. A 65-year-old Patient with Osteopoikilosis and Bilateral Pleural Effusion. Case Report
6. Rheuma und Gastroenterologie
7. Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
8. FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
9. Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial.
10. Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie
11. Real-world effectiveness and safety of SDZ ETN, an etanercept biosimilar, in patients with rheumatic diseases: final results from multi-country COMPACT study
12. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
13. Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
14. Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting
15. Evaluation of patient’s characteristics associated with severity of morning stiffness in patients with ankylosing spondylitis: Results from the German cohort of the real world evidence study 'INVISIBLE'
16. Add-on or withdrawal of methotrexate do not impact efficacy of IL12/23 inhibition in active PsA: Data from the multicenter investigator-initiated randomized placebo-controlled MUST trial
17. Begutachtungsfragen
18. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
19. Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study
20. Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care
21. Muscle Ultrasound
22. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
23. Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study
24. A MATHEMATICAL APPROACH RECONSTRUCTING J. S. BACH'S KEYBOARD TEMPERAMENT
25. CONSIDERING THE TEMPERING TONALITY B-MAJOR IN PART II OF THE "WELL-TEMPERED CLAVIER" II
26. Das wohltemperirte Clavier: Implications de l'accord inégal pour l'œuvre et son autographe
27. A propos d'une réimpression de la Musicalische Temperatur (1691) de Werckmeister
28. Le tempérament inégal de Werckmeister/Bach et l'alphabet numérique de Henk Dieben
29. Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging
30. Rheuma oder kein Rheuma?: Schmerzen in den Fingergelenken
31. Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
32. Worauf dicke Finger hindeuten: Arthritis, Arthrose oder Ödeme
33. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
34. ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
35. The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age
36. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
37. Use of a self-injection assessment questionnaire to assess patient satisfaction with a self-injection device in rheumatoid arthritis patients receiving SDZ-ETN (GP2015) in Germany: An interim analysis of the real-world COMPACT study
38. Bildgebende Verfahren in der Rheumatologie: Sonographie bei rheumatoider Arthritis
39. The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy
40. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
41. Begutachtung von Patienten mit seronegativen Spondylarthropathien
42. Systematic analysis of injection-site pain and reactions caused by subcutaneous administration of the adalimumab biosimilar FKB327 versus the adalimumab reference product via different delivery methods
43. Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies
44. Identification of Interleukin-7 as a Candidate Disease Mediator in Spondylarthritis
45. Spontanes Auftreten von ventrikulären Tachykardien bei Spondylitis ankylosans
46. Ungeklärte Belastungsdyspnoe bei einem sportlich aktiven Bechterew-Patienten
47. In the real world clinical setting Etanercept Biosimilar SB4 (Benepali) demonstrates equivalent safety and effectiveness in biologic naive as well as with Enbrel, pretreated patients with RA, SpA or PsA
48. Einfluss der Kombinationstherapie von Rituximab und Lefluonmid auf Patient-Reported Outcomes und Funktion in Patienten mit Rheumatoider Arthritis: Ergebnisse einer multizentrischen, randomisierten, Placebo-kontrollierten Investigator initiierten Studie (AMARA-Study)
49. Retrospektiver Vergleich der Wirksamkeit und Verträglichkeit von Remicade mit dem Biosimilar Infliximab Inflectra über ein Beobachtungsintervall von 30 Monaten
50. MOESM4 of FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.